TrialThe American journal of psychiatry2011

A randomized trial examining the effectiveness of switching from olanzapine, quetiapine, or risperidone to aripiprazole to reduce metabolic risk: comparison of antipsychotics for metabolic problems (CAMP).

T Scott Stroup et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.